Testing effectiveness (Phase 2)WithdrawnNCT03239600
What this trial is testing
Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS)
Who this might be right for
Autoimmune Diseases
GlaxoSmithKline